Interwest Venture Management CO Eiger Bio Pharmaceuticals, Inc. Transaction History

Interwest Venture Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$3.84 - $9.74 $783,083 - $1.99 Million	-203,928 Reduced 26.66%	560,990 $4.66 Million
Q2 2019 Jul 29, 2019	SELL	$9.54 - $14.96 $32,121 - $50,370	-3,367 Reduced 0.44%	764,918 $8.11 Million
Q1 2019 Apr 15, 2019	SELL	$10.31 - $14.38 $4.88 Million - $6.81 Million	-473,583 Reduced 38.13%	768,285 $10.7 Million
Q4 2018 Jan 04, 2019	SELL	$8.63 - $12.4 $3.09 Million - $4.44 Million	-357,724 Reduced 22.36%	1,241,868 $12.6 Million
Q3 2017 Oct 11, 2017	BUY	$7.7 - $11.55 $12.3 Million - $18.5 Million	1,599,592	1,599,592 $17.6 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Interwest Venture Management CO, based on Form 13F filings with the SEC.

Stay updated on Interwest Venture Management CO with notifications on news.